Text

Probiotic-based hydrogel can treat yeast infection, support a healthy vaginal microbiota

The findings of a recent study suggest that combining Lactobacillus probiotics with nanozymes can help treat Candida vaginitis and help the growth of beneficial vaginal microbes.

MICRO beyond the analysis: linking people, research and innovation

The microbiological laboratory applying AI to specific analysis activities.

Alphyn Biologics Reports Encouraging Interim Results of Phase 2a Trial for Atopic Dermatitis with Secondary Bacterial Infection

Topical treatment is achieving all endpoints for efficacy and safety in mild, moderate, and severe atopic dermatitis.

Microbiota transplant after gastric bypass improves metabolism in mice

The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.

Nestlé partners with APC Microbiome Ireland

The collaboration will focus on various aspects of the human microbiome that could benefit new product development.

A cross-sectional study on the link between gut microbiota and inflammation in bipolar depression

Depressed BD patients present significant alterations in the taxonomic compositions of their gut microbiota, and this may be related to inflammatory pathways and depression severity.

How infections alter the population of a gut microbe

The findings of a recent study suggest that a mild gastrointestinal infection can alter gut commensal populations in ways that boost the commensal’s ability to proliferate during an infection.

A new mechanism in rheumatoid arthritis aggravation: Fusobacterium Nucleatum-mediated release of FadA-containing outer membrane vesicles

The findings of a recent study imply that Fusobacterium nucleatum may play a causal role in worsening RA, offering potential therapeutic targets for effectively alleviating RA symptoms.

IPC 2023 and the postbiotics session: the gathering of the different parties 

The highlights of the Postbiotics Discussion Panel that took place in Bratislava during IPC 2023.

Additional Infant Bacterial Therapeutics product receives FDA orphan drug designation

The FDA has granted orphan drug designation for IBT’s product IBP-1016 for gastroschisis.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.